FDA issues guidance on preventing antibiotic cross-contamination
April 19, 2011Manufacturing and Production FDA, GMP, pharma manufacturing
The FDA has published a new guidance document to help drugmakers prevent cross-contamination of pharmaceuticals with non-penicillin beta-lactam antibiotics. The …
Organogenesis to build ‘largest automated living cell facility’
April 19, 2011Manufacturing and Production Cell biology, Organogenesis, pharma manufacturing
Regenerative medicine specialist Organogenesis has started construction of an automated manufacturing facility for human cells, which it claims will be …
J&J and Merck reach compromise on arthritis drug rights
April 19, 2011Sales and Marketing Johnson & Johnson, Merck & Co, Remicade, Simponi
Johnson & Johnson and Merck & Co have agreed to split the regional rights to arthritis drugs Remicade and Simponi …
GlaxoSmithKline OTC sale puts two plants on the block
April 19, 2011Manufacturing and Production GSK, US, pharma manufacturing
GlaxoSmithKline’s decision to sell off a swathe of over-the-counter medicines means that a manufacturing facility in Memphis, Tennessee, has been …
Boehringer’s Pradaxa recommended for expanded European licence
April 18, 2011Sales and Marketing Boehringer Ingelheim, CHMP, Pradaxa
Pradaxa is on course to expand its European licence with a recommendation from the CHMP for a new indication in …
Tim Mustill and Jenny Hepburn join InterPhase
April 18, 2011Sales and Marketing appointment, sales and marketing
KnowledgePoint360 Group has appointed Tim Mustill and Jennifer Hepburn to key positions within its strategic consulting practice InterPhase. Tim has …
Phase III boost for Pfizer’s oral arthritis drug
April 18, 2011Research and Development, Sales and Marketing Pfizer, rheumatoid arthritis, tofacitinib
Pfizer’s rheumatoid arthritis treatment tofacitinib has induced clinical remission of the disease according to one-year data from a phase III …
TBA contamination prompts Topamax recall
April 18, 2011Manufacturing and Production Johnson and Johnson, recalls
Another Johnson & Johnson business unit has decided to recall medicines because of a mouldy smell thought to be caused …
VBP: a fait accompli or room for manoeuvre?
April 18, 2011Sales and Marketing value-based pricing
The pharma industry is seeking a compromise on the UK’s proposed value- based pricing, which promises to revolutionise the country’s …
Genzyme MS drug shines in head-to-head trial with Rebif
April 18, 2011Research and Development, Sales and Marketing Genzyme, Lemtrada, Sanofi-Aventis, relapsing multiple sclerosis
Genzyme’s multiple sclerosis candidate Lemtrada has impressed in a new phase II head-to-head trial. Five years’ worth of mid-stage data …
Fishawack gains industry experts
April 15, 2011Medical Communications Fishawhack, PR
The Fishawack Group has gained industry experts Linda Harris and Jo Jarvis to expand its stakeholder relations and thought leader …
GlaxoSmithKline to drop Alli and other OTC products
April 15, 2011Research and Development, Sales and Marketing Alli, GSK, OTC, Tyverb
GlaxoSmithKline is to sell off its weight loss drug Alli and other less profitable non-prescription drugs. GSK announced its decision …
Elliott maintains pressure on Actelion
April 15, 2011Sales and Marketing Actelion, pharma mergers and acquisitions
Investment firm Elliott Advisors is maintaining its push for a new leadership team at Actelion.The investment firm is the biggest …
Nurses’ vote of no confidence a further blow to Lansley
April 14, 2011Health and Social Care Bill, NHS reforms, Royal College of Nursing
The Royal College of Nurses has voted overwhelmingly against Andrew Lansley’s health reforms, as he receives a vote of no …
Pharma manufacturing news in brief
April 14, 2011Manufacturing and Production Cangene, Chirotech, Grand River Aseptic Manufacturing, Perrigo, West Pharmaceutical Services
India’s Dr Reddy’s Laboratories has opened a new headquarters for its UK subsidiary ChiroTech, along with a new purpose-built laboratory …
Roche growth stalls after Avastin setback
April 14, 2011Research and Development, Sales and Marketing Roche
Revenues at Roche flattened out in the first three months of 2011, as Avastin sales declined in the US and Europe. Group …
Watermeadow continues to grow
April 14, 2011Research and Development Watermeadow, awards, employees, growth
Watermeadow Medical is delighted to welcome seven new staff to its UK offices. The appointments have been made as demand …
GPs asked to squeeze drugs bill
April 14, 2011Sales and Marketing AZ, GPs, NHS, NICE, prescribing
GPs are being asked not to prescribe NICE-approved drugs in order to cut costs.In the last year more than half …
Lonza expands UK facility, bio business reports growth
April 13, 2011Manufacturing and Production, Research and Development, Sales and Marketing Benlysta, Lonza, Slough, manufacturing
Swiss contract manufacturer and fine chemicals company Lonza has said it plans to expand its biopharmaceutical production unit in Slough, …
FDA committee votes in Afinitor’s favour
April 13, 2011Research and Development, Sales and Marketing
The FDA advisory committee has unanimously backed Novartis’ Afinitor for neuroendocrine tumours of pancreatic origin. The recommendation comes from the …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
